Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are Mood Disorder Patients Included in Medical Cannabis Trials? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The make-up of cannabis trial populations is key to understanding how relevant findings are for depression, bipolar disorder, and other mood disorders. While many cannabis studies focus on chronic pain, epilepsy, or multiple sclerosis, psychiatric conditions are often under-represented. This means evidence for patients with a mental health condition  is still relatively limited. 

Some trials do include participants with mood-related symptoms, but these are usually secondary measures rather than primary targets. As a result, the role of cannabis in treating depression or bipolar disorder remains less clear than in physical health conditions. 

Can I use Medical Cannabis for Pain Relief?

Cannabis Trials and Mental Health Inclusion 

Examining cannabis trial populations highlights how participant groups are selected and what this means for psychiatric research. 

Inclusion Criteria for Cannabis Trials 

Most inclusion criteria for cannabis trials focus on physical illnesses. When mood disorders are included, they are often part of smaller, exploratory studies rather than large-scale trials. 

Mood Disorder Participants 

There are examples of mood disorder participants being studied, particularly for sleep problems, anxiety, or depressive symptoms, but they remain a minority compared to other patient groups. 

Clinical Trial Demographics 

The clinical trial demographics of cannabis research reveal a gap: people with psychiatric conditions are often excluded, limiting the strength of evidence for mental health outcomes. 

In summary, cannabis trial populations rarely prioritise mood disorder patients, leaving significant gaps in the data. Stronger inclusion will be essential for understanding whether cannabis has a reliable role in psychiatric care. 

For individuals curious about how research applies to their condition, providers like LeafEase can offer personalised consultations to bridge the gap between clinical evidence and lived experience. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories